SCHEMBL2356897

SCHEMBL2356897

BrC1CCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25690600 0.92
SCHEMBL14476043 0.81
SCHEMBL264306 0.81
SCHEMBL5785673 0.81
SCHEMBL29991284 0.78
SCHEMBL29991682 0.78
SCHEMBL3599832 0.77
Fluoride SCHEMBL15271706 0.69
SCHEMBL19985099 0.69 ALDH1A1 (0.35)
SCHEMBL14683300 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0641346-B1 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES LEPETIT SPA (IT) 1996-05-29 EP claimed
US-3931236-A Oxidation and dehydrohalogenation of halotetrahydropyrans PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US claimed
US-12478621-B2 Substituted aminoquinolones as dgkalpha inhibitors for immune activation DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2025-11-25 US disclosed
WO-2025110780-A1 NOVEL HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS DNA POLYMERASE THETA INHIBITORS FOR THE PREVENTION OR TREATMENT OF CANCER DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2025-05-30 WO disclosed
CN-120040437-A Novel heterocyclic compound and pharmaceutical composition comprising same 株式会社大熊制药 2025-05-27 CN disclosed
US-11998539-B2 Substituted aminoquinolones as DGKalpha inhibitors for immune activation BAYER AKTIENGESELLSCHAFT (DE) 2024-06-04 US disclosed
EP-3768671-B1 SUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS PRMT5 INHIBITORS AURIGENE ONCOLOGY LTD (IN) 2024-05-22 EP disclosed
US-20240158394-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. 2024-05-16 US disclosed
WO-2024059200-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2024-03-21 WO disclosed
US-11918582-B2 Pyrazole pyrimidine compounds and uses thereof RAPT THERAPEUTICS, INC. (US) 2024-03-05 US disclosed
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME Halia Therapeutics, Inc. 2023-07-06 US disclosed
WO-2003010155-A1 METHOD FOR PRODUCING NOVEL SPINOSYN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-02-06 WO disclosed
US-6060207-A LOW IN ABSORPTION OF A LIGHT SOURCE OF SHORT WAVELENGTH AND EXCELLENT IN DRY ETCH RESISTANCE; COMPRISES A COMPOUND HAVING A TERPENOID SKELETON KABUSHIKI KAISHA TOSHIBA (JP) 2000-05-09 US disclosed
CN-1032786-A N-acyl amino acid derivative and uses thereof BANYU PHARMA CO LTD (JP) 1989-05-10 CN disclosed
US-4818431-A ELECTROOPTICAL DISPLAY ELEMENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-04-04 US disclosed
EP-0117476-B1 TETRAHYDROPYRANES MERCK PATENT GmbH (DE) 1987-09-16 EP disclosed
US-4569925-A OXIDATION CATALYST FOR HYDROCARBONS EXXON RESEARCH & ENGINEERING CO. (US) 1986-02-11 US disclosed
EP-0117476-A1 Tetrahydropyranes MERCK PATENT GmbH (DE) 1984-09-05 EP disclosed
US-4043943-A Process for producing a mixed oxide of vanadium and phosphorus having an improved intrinsic surface area CHEVRON RESEARCH COMPANY (US) 1977-08-23 US disclosed
US-3931236-A Oxidation and dehydrohalogenation of halotetrahydropyrans PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US disclosed